Literature DB >> 3978122

Activation of peritoneal macrophages by lysophosphatidylcholine.

B Z Ngwenya, N Yamamoto.   

Abstract

Lysophosphatidylcholine (lyso-PC), a product of inflammation induced by infectious and other agents, is able to stimulate mouse peritoneal macrophages to ingest target cells coated with IgG but not IgM regardless of the presence of complement. In vitro treatment of mouse resident peritoneal macrophages (adherent cells) alone with lyso-PC stimulated spreading activity but did not enhance ingestion activity of macrophages. However, when mixed cultures of adherent and nonadherent (lymphocytes) cells were treated with lyso-PC, macrophage ingestion activity of IgG-coated target cells (i.e., via Fc-mediated ingestion) was markedly enhanced. Analysis of lyso-PC activation process of macrophages for ingestion activity suggests that nonadherent (lymphocytes) cells are required for the induction of the manifestation of ingestion capacity. This requirement was also met by addition of untreated nonadherent cells to treated adherent cells. Thus, the activation mechanism of macrophages by lyso-PC for ingestion requires contribution of lymphocytes to promote enhanced ingestion activity. Since lyso-PC is a metabolite of a representative membrane phospholipid, we propose that lyso-PC and other lysophospholipids are mediators for activation of macrophages regardless of the type of inflammation-causative agent.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978122     DOI: 10.1016/0304-4165(85)90175-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

1.  Activation of macrophages by ether analogues of lysophospholipids.

Authors:  N Yamamoto; B Z Ngwenya; T W Sery; R A Pieringer
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Identification of the serum factor required for liposome-primed activation of mouse peritoneal macrophages. Modified alpha 2-macroglobulin enhances Fc gamma receptor-mediated phagocytosis of opsonized sheep red blood cells.

Authors:  M Murai; Y Aramaki; S Tsuchiya
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

3.  The contribution of a serum component(s) modified by B cells to the mechanism for macrophage activation by liposomes.

Authors:  Y Aramaki; M Murai; S Tsuchiya
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

4.  Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line.

Authors:  Yukiyo Toyohara; Susumu Hashitani; Hiromitsu Kishimoto; Kazuma Noguchi; Nobuto Yamamoto; Masahiro Urade
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

5.  Participation of serum proteins in the inflammation-primed activation of macrophages.

Authors:  N Yamamoto; N P Willett; D D Lindsay
Journal:  Inflammation       Date:  1994-06       Impact factor: 4.092

6.  In vivo and in vitro activation of macrophages with a cyanine photosensitizing dye, platonin.

Authors:  Y Nakagawa; S Homma; I Yamamoto; M Banno; H Nakazato; H Imanaga; N Yamamoto
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

7.  Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.

Authors:  N Yamamoto; S Homma; J G Haddad; M A Kowalski
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

8.  Regulation of inflammation-primed activation of macrophages by two serum factors, vitamin D3-binding protein and albumin.

Authors:  N Yamamoto; R Kumashiro; M Yamamoto; N P Willett; D D Lindsay
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  Role of lipid structure in the activation of phospholipase A2 by peroxidized phospholipids.

Authors:  L R McLean; K A Hagaman; W S Davidson
Journal:  Lipids       Date:  1993-06       Impact factor: 1.880

10.  Activation of Fc receptor-mediated phagocytosis by mouse peritoneal macrophages following the intraperitoneal administration of liposomes.

Authors:  Y Aramaki; M Murai; S Tsuchiya
Journal:  Pharm Res       Date:  1994-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.